Nasdaq · Healthcare
EDAP TMS SA (FOCL)
As-reported financials and recent SEC filings for EDAP TMS SA, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$70.5M
Net income
$-29.2M
Net margin
-41.5%
Diluted EPS
$-0.78
ROE
-150.7%
P/E (TTM)
—
Market cap
—
Debt / equity
0.8×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $70.5M | $69.4M | $60.4M | $55.1M | $44.1M |
| Gross profit | $30.0M | $28.7M | $24.4M | $24.2M | $18.4M |
| Operating income | $-24.7M | $-22.2M | $-19.8M | $-4.3M | $-1.6M |
| Net income | $-29.2M | $-20.6M | $-21.2M | $-2.9M | $699,890 |
| Diluted EPS | $-0.78 | $-0.55 | $-0.57 | $-0.09 | $0.02 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-26
View on EDGAR →8-K2026-06-01
View on EDGAR →8-K2026-05-29
View on EDGAR →ARS2026-05-14
View on EDGAR →DEFA14A2026-05-14
View on EDGAR →DEFA14A2026-05-14
View on EDGAR →DEF 14A2026-05-14
View on EDGAR →42026-05-13
View on EDGAR →Largest Healthcare peers
Go deeper on FOCL
Search EDAP TMS SA’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.